tiprankstipranks
Trending News
More News >
IMAX Corporation (IMAX)
:IMAX

IMAX (IMAX) AI Stock Analysis

Compare
592 Followers

Top Page

IM

IMAX

(NYSE:IMAX)

Rating:77Outperform
Price Target:
$33.00
▲(25.48%Upside)
IMAX's overall stock score is buoyed by strong financial performance and growth potential from strategic corporate initiatives. While technical indicators and earnings sentiment are positive, high valuation metrics present some risk. The company's proactive steps to enhance shareholder value and expand its market presence contribute positively to the score.
Positive Factors
Earnings
IMAX's Q2 box office performance exceeded forecasts, generating $278 million, which led to an increase in revenue estimates.
Market Position
IMAX is in a unique position in premium cinema with a powerful slate of upcoming titles and a lean operating model that drives strong margin expansion and long-term earnings leverage.
Strategic Partnerships
IMAX continues to deepen its relationships with studios, filmmakers, and streamers, driving market share gains and network growth.
Negative Factors
Market Competition
Filmmakers wield significant leverage with development and distribution partners; Greta Gerwig, for example, championed IMAX for Narnia, securing an unprecedented Netflix deal with a four-week exclusive theatrical window before streaming.

IMAX (IMAX) vs. SPDR S&P 500 ETF (SPY)

IMAX Business Overview & Revenue Model

Company DescriptionIMAX Corporation is a world leader in entertainment technology, specializing in immersive cinematic experiences through its large-format theaters and cutting-edge projection systems. The company operates within the entertainment and media sectors, offering moviegoers a unique viewing experience through its proprietary IMAX digital, laser, and 3D technologies. In addition to its theater network, IMAX licenses its technology to commercial multiplex operators, enabling them to deliver the IMAX experience.
How the Company Makes MoneyIMAX Corporation generates revenue through several key streams. Primarily, the company earns money by leasing its proprietary IMAX systems to commercial theaters under joint revenue sharing arrangements, where it receives a percentage of box office receipts. Additionally, IMAX earns from the sale of its projection systems and related equipment. The company also generates revenue through maintenance services, the digital re-mastering of films into the IMAX format (IMAX DMR), and licensing its technology to third-party theaters. Significant partnerships with major film studios to release blockbuster movies in the IMAX format further bolster its earnings, as these partnerships often lead to higher ticket prices and increased audience turnout.

IMAX Earnings Call Summary

Earnings Call Date:Apr 23, 2025
(Q1-2025)
|
% Change Since: 9.13%|
Next Earnings Date:Jul 24, 2025
Earnings Call Sentiment Positive
IMAX Corporation reported a record-breaking first quarter with significant box office growth and expansion in system signings. While concerns about Hollywood imports to China exist, the company's local language strategy and strong financial performance paint a positive outlook.
Q1-2025 Updates
Positive Updates
Record-Breaking Global Box Office
IMAX Corporation achieved nearly $300 million in global box office, marking its best first quarter ever. Chinese New Year exceeded expectations with $182 million, triple the previous record.
Significant Growth in System Signings
IMAX signed agreements for 101 new and upgraded systems worldwide, compared to 130 for all of 2024. This includes a major agreement with AMC and international expansion in Japan, Europe, and North America.
Strong Financial Performance
The company reported a 10% increase in revenue to $87 million and a 17% increase in technology products and services revenue. Adjusted EBITDA grew by 15% with a margin of 42.7%.
Successful Local Language Strategy
Local language films accounted for 68% of the box office in Q1 2025. IMAX set records in China and Japan with local language releases and is expanding its content portfolio in fast-growing markets.
Negative Updates
Moderate Reduction in Hollywood Imports to China
There is a moderate reduction in Hollywood imports announced by the China Film Administration, targeting films with limited box office potential.
Potential Economic Concerns in China
Questions arose about the potential impact of an economic slowdown in China on consumer attendance, though recent performance has been strong.
Company Guidance
During the IMAX Corporation's First Quarter 2025 Earnings Conference Call, CEO Richard Gelfond highlighted the company's strong start to the year with nearly $300 million in global box office revenue, marking their best first quarter ever. The company achieved double-digit growth in revenue and adjusted EBITDA, with an adjusted EBITDA margin of 43%. IMAX signed agreements for 101 new and upgraded systems worldwide, compared to 130 for all of 2024, and installed 21 systems, marking their second-best first quarter for installations. The Chinese New Year box office hit $182 million, triple their previous record, contributing to a growth in local language films, which accounted for 68% of the box office in Q1 2025. The company maintained its guidance for a record $1.2 billion in global box office for the year, driven by a strong slate of upcoming releases and a promising outlook for 2026 and beyond.

IMAX Financial Statement Overview

Summary
IMAX exhibits a promising financial trajectory with improved profitability, stable leverage, and strong cash flow generation. However, monitoring debt levels and sustaining revenue growth are crucial for maintaining momentum.
Income Statement
75
Positive
IMAX has shown solid improvement in its profitability metrics. The TTM gross profit margin stands strong at 54.6%, and the net profit margin has improved to 12.6% from a negative position in prior years. Revenue growth has stabilized post-pandemic, with a slight increase in TTM revenue compared to the previous year. EBIT and EBITDA margins are healthy, indicating efficient operations.
Balance Sheet
70
Positive
The company maintains a stable financial position with a debt-to-equity ratio of 0.77, indicating a balanced leverage. ROE improved to 15.2% in the TTM, showcasing enhanced profitability for shareholders. The equity ratio slightly decreased to 35.3%, reflecting a cautious approach to asset financing.
Cash Flow
80
Positive
IMAX demonstrated strong cash flow management with a significant increase in free cash flow, growing by 79.0% in the TTM. The operating cash flow to net income ratio is robust at 1.95, and free cash flow to net income ratio stands at 1.17, indicating effective cash conversion from profits.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue359.75M352.21M374.84M300.81M254.88M137.00M
Gross Profit196.49M190.20M214.34M156.35M134.41M21.54M
EBITDA100.33M111.28M112.96M52.77M74.16M-69.41M
Net Income25.11M26.06M25.34M-22.80M-22.33M-143.78M
Balance Sheet
Total Assets848.30M830.40M814.67M821.15M883.25M997.75M
Cash, Cash Equivalents and Short-Term Investments97.07M100.59M76.20M97.40M189.71M317.38M
Total Debt279.60M266.26M252.06M263.02M226.11M305.68M
Total Liabilities464.01M452.18M469.08M491.39M452.88M532.98M
Stockholders Equity299.50M299.47M273.14M263.36M356.08M385.49M
Cash Flow
Free Cash Flow53.03M29.62M25.78M-15.30M-11.71M-32.27M
Operating Cash Flow88.76M70.84M58.62M17.32M6.07M-23.01M
Investing Cash Flow-48.70M-41.22M-31.79M-53.29M-7.00K-9.26M
Financing Cash Flow-24.60M-6.04M-48.53M-58.51M-132.72M240.57M

IMAX Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price26.30
Price Trends
50DMA
26.98
Negative
100DMA
25.96
Positive
200DMA
24.66
Positive
Market Momentum
MACD
-0.12
Positive
RSI
40.10
Neutral
STOCH
25.05
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IMAX, the sentiment is Neutral. The current price of 26.3 is below the 20-day moving average (MA) of 27.77, below the 50-day MA of 26.98, and above the 200-day MA of 24.66, indicating a neutral trend. The MACD of -0.12 indicates Positive momentum. The RSI at 40.10 is Neutral, neither overbought nor oversold. The STOCH value of 25.05 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IMAX.

IMAX Risk Analysis

IMAX disclosed 29 risk factors in its most recent earnings report. IMAX reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

IMAX Peers Comparison

Overall Rating
UnderperformOutperform
Sector (58)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
$1.43B58.069.00%-1.98%-1.18%
CNCNK
65
Neutral
$3.43B19.7271.46%1.04%-0.80%13.07%
63
Neutral
$1.83B13.891222.83%5.81%133.05%
58
Neutral
kr13.94B3.6419.17%3.83%-7.94%154.39%
AMAMC
49
Neutral
$1.23B20.03%-5.43%26.07%
* Communication Services Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IMAX
IMAX
26.30
8.96
51.67%
CNK
Cinemark Holdings
28.81
7.37
34.37%
AMC
AMC Entertainment
2.95
-2.27
-43.49%
MSGE
Madison Square Garden Entertainment Corp.
38.20
1.63
4.46%

IMAX Corporate Events

Shareholder MeetingsStock BuybackBusiness Operations and Strategy
IMAX Expands Share Repurchase Program by $100 Million
Positive
Jun 13, 2025

On June 11, 2025, IMAX Corporation held its Annual General Meeting where shareholders elected directors, approved PricewaterhouseCoopers LLP as auditors, and endorsed executive compensation. On June 12, 2025, IMAX announced a $100 million increase to its share repurchase program, extending it through June 30, 2027, bringing the total authorization to $500 million. This move reflects IMAX’s strategic focus on enhancing shareholder value and maintaining a strong market position.

The most recent analyst rating on (IMAX) stock is a Hold with a $20.00 price target. To see the full list of analyst forecasts on IMAX stock, see the IMAX Stock Forecast page.

Executive/Board Changes
IMAX Appoints Jose Zlatar as New Accounting Officer
Positive
Apr 25, 2025

On April 23, 2025, IMAX Corporation’s Board of Directors appointed Jose Zlatar as the new principal accounting officer, effective April 30, 2025. Zlatar, who joined the company in February 2025 as Senior Vice President, Finance, will take over the accounting responsibilities from CFO Natasha Fernandes, who will continue as the principal financial officer. Zlatar brings extensive experience from his previous roles at Canadian National Railway and Yamana Gold Inc., and his appointment is expected to strengthen IMAX’s financial leadership and operations.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 14, 2025